Afshin Safaei-Asl
*1 Division of Nephrology, Department of Pediatrics, Guilan University of Medical Sciences, Rasht, Iran.
Implication for health policy/practice/research/medical
education
CKD-MBD explains disturbances of calcium, phosphorus,
PTH, and vitamin D metabolism in CKD patients. The
target management of CKD-MBD is to manage secondary
hyperparathyroidism and avoid the development of extraskeletal
calcifications. The treatment of these problems in
children needs a specific view to achieve adequate growth
process and prevention of cardiovascular problems.